Copyright
©The Author(s) 2017.
World J Cardiol. Jul 26, 2017; 9(7): 594-599
Published online Jul 26, 2017. doi: 10.4330/wjc.v9.i7.594
Published online Jul 26, 2017. doi: 10.4330/wjc.v9.i7.594
Drug | Mechanism | Clinical trials and year | Results on HF symptoms |
Nestiride | Increasing natriuretic peptide activity | VMAC, 2000[20] PRECEDENT, 2002[21] ASCENT-HF, 2009[22] | Improved BP and dyspnea Less cardiac arrhythmias More hypotension |
Candoxatril | NPi | Single-centered investigation with only a limited number of patients[23-25] | More exercise tolerance Increase in vascular resistance |
Omapatrilat | NPi | IMPRESS, 2000[26] OVERTURE, 2002[27] OCTAVE, 2004[28] | More exercise tolerance Increase in angioedema Reduction in BP Lower mortality |
LCZ696 | NPi | PARAMOUNT, 2012[29] PARADIGM, 2014[30,31] PARAGON, ongoing[32] | Reduction in BP Improved ejection fraction Lower mortality No change in angioedema |
- Citation: Patel N, Gluck J. Is Entresto good for the brain? World J Cardiol 2017; 9(7): 594-599
- URL: https://www.wjgnet.com/1949-8462/full/v9/i7/594.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i7.594